Auxilium sets sights on wider indication for Xiaflex in Dupuytren's
This article was originally published in Scrip
Auxilium's Dupuytren's contracture treatment Xiaflex (collagenase clostridium histolyticum) can be used to treat multiple cords in one procedure, top-line data form a Phase III study suggest. The results from 60 patients prepare the ground for a larger study due to begin soon that could lead to an application to broaden its indication in the non-surgical treatment of this disease.
You may also be interested in...
Positive Phase II data for Aptinyx’s novel NMDA receptor modulator are strong enough to take the product into a pivotal study in this difficult-to-treat area.
Orchard Therapeutics is on the cusp of the first approval for its ex vivo gene therapy, Libmeldy, for metachromatic leukodystrophy.
Gilead/Kite’s second CAR-T product is given the go-ahead for approval by the CHMP for mantle cell lymphoma.